Improving cancer detection using advanced PCR techniques
Significant expansion of spectral multiplexing in PCR
This study is working on a new way to improve a test that checks for multiple genetic markers at the same time, making it easier and quicker to diagnose cancer early, so patients can get the help they need faster.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lamprogen, INC. NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10840378 on NIH RePORTER |
What this research studies
This research focuses on enhancing the capabilities of real-time PCR to detect multiple genetic sequences simultaneously, which is crucial for early cancer diagnosis and screening. By developing a new method that allows for a significant increase in the number of sequences that can be analyzed at once, this project aims to make PCR more effective and accessible for clinical use. The approach seeks to combine the speed and cost-effectiveness of real-time PCR with the multiplexing capabilities typically associated with next-generation sequencing. This could lead to faster and more accurate diagnostic tests for cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for cancer who require genetic screening or diagnostic testing.
Not a fit: Patients who have already been diagnosed with cancer and are not seeking further genetic testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and cost-effective cancer screening methods, improving early detection rates.
How similar studies have performed: Previous research has shown promise in enhancing PCR techniques for diagnostic purposes, indicating that this approach could build on established successes.
Where this research is happening
Seattle, United States
- Lamprogen, INC. — Seattle, United States (Active)
Researchers
- Principal investigator: Yu, Jiangbo — Lamprogen, INC.
- Study coordinator: Yu, Jiangbo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.